Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 12, 2016Chemical Reviews

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYu ZhouNingbo UniversityJWJiang WangJiangxi University of Traditional Chinese MedicineZGZhanni GuDalian Ocean University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhou et al. (2016) studied this question.

synapsesocial.com/papers/69d6c7fbabefa4d4d4aa80a3https://doi.org/10.1021/acs.chemrev.5b00392
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lewis acid-catalyzed regioselective synthesis of chiral α-fluoroalkyl amines via asymmetric addition of silyl dienolates to fluorinated sulfinylimines2013 · 42 citations
  2. 2Synthesis of New DPP-4 Inhibitors Based on a Novel Tricyclic Scaffold2015 · 25 citations
  3. 3Enzalutamide for the Treatment of Prostate Cancer: Results and Implications of the AFFIRM Trial2014 · 13 citations
  4. 4Asymmetric synthesis of quaternary α-fluoro-β-keto-amines via detrifluoroacetylative Mannich reactions2015 · 59 citations